Asset Dedication LLC’s NanoViricides NNVC Stock Holding History

Asset Dedication LLC’s Portfolio NNVC Stock Details NNVC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2K	Hold	1,450	–	–	﹤0.01%	1038
2026 Q1	$1.32K	Hold	1,450	–	–	﹤0.01%	999
2025 Q4	$1.64K	Hold	1,450	–	–	﹤0.01%	1019
2025 Q3	$2.07K	Hold	1,450	–	–	﹤0.01%	1017
2025 Q2	$2.03K	Hold	1,450	–	–	﹤0.01%	1031
2025 Q1	$1.7K	Hold	1,450	–	–	﹤0.01%	979
2024 Q4	$2.07K	Hold	1,450	–	–	﹤0.01%	968
2024 Q3	$2.17K	Hold	1,450	–	–	﹤0.01%	1001
2024 Q2	$2.49K	Hold	1,450	–	–	﹤0.01%	1040
2024 Q1	$2K	Hold	1,450	–	–	﹤0.01%	896
2023 Q4	$1K	Hold	1,450	–	–	﹤0.01%	946
2023 Q3	$2K	Hold	1,450	–	–	﹤0.01%	902
2023 Q2	$2K	Hold	1,450	–	–	﹤0.01%	872
2023 Q1	$2K	Hold	1,450	–	–	﹤0.01%	859
2022 Q4	$2K	Hold	1,450	–	–	﹤0.01%	875
2022 Q3	$3K	Buy	+1,450	New	+$3.16K	﹤0.01%	789

Other funds holding NNVC

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCM

Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

MFS

Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Asset Dedication LLC's NNVC Position: Q2 2026 in Review

Asset Dedication LLC held its NanoViricides (NNVC) position steady in Q2 2026 at 1,450 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #1038.

Asset Dedication LLC first reported a position in NNVC in Q3 2022 and has held it in 16 quarters since. The position peaked at $3K in Q3 2022. 48 funds tracked by Wall St. Rank hold NNVC as of Q2 2026.

Asset Dedication LLC held 1,450 shares of NanoViricides worth $2K as of Q2 2026.
Asset Dedication LLC left its NanoViricides share count unchanged in Q2 2026.
NanoViricides made up ﹤0.01% of Asset Dedication LLC's portfolio in Q2 2026, its #1038 holding.
Asset Dedication LLC first reported a position in NanoViricides in Q3 2022 and has held it in 16 quarters since.
Asset Dedication LLC's NanoViricides position peaked at $3K in Q3 2022.
48 funds tracked by Wall St. Rank held NanoViricides as of Q2 2026.

Based on Asset Dedication LLC's 13F filing for Q2 2026, filed 30 Jul 2026.